GHK-Cu
From £22
- Home
- Regenerative
- BPC-157 & TB-500 Blend
In stock, ships today
- Purity: ≥99% (HPLC, per constituent)
- Independent lab report for the batch you receive
- For laboratory research use only
£48
- Only 21 left in the UK warehouse
- Order within 12h 10m for dispatch today, estimated delivery Thu 12 Nov
- Free UK delivery over £100
- Discreet, plain unbranded packaging
Third-party lab report
Batch BTB20.266 99% purity Tested 23 Jul 2026
Pay by bank
About BPC-157 & TB-500 Blend
This research blend combines BPC-157 (a pentadecapeptide derived from a gastric protein sequence) and the Thymosin Beta-4 analogue TB-500. The combination is used in in vitro and preclinical models to study the interaction between angiogenic signalling pathways and cytoskeletal organisation.
Primary areas of investigation
- Angiogenic signalling pathway interaction
- Fibroblast and endothelial migration assays
- Cytoskeletal dynamics research
- EGR-1 gene expression studies
- Connective tissue cell culture models
- Extracellular matrix research
Mechanism
The blend brings together two complementary research pathways. BPC-157 is investigated for its association with EGR-1 gene expression and VEGF-related signalling cascades. TB-500 acts through G-actin binding, influencing cytoskeletal organisation in experimental systems. Research focuses on the interaction between these pathways in musculoskeletal and connective tissue model systems.
Delivery and returns
Shipped in plain, unbranded packaging from our United Kingdom warehouse. Damaged on arrival? Tell us within 48 hours and we’ll put it right. Shipping and returns
For laboratory research use only. Not for human or veterinary use.
